Companies: 10,795·Total market cap: $144.5T
Humana Inc.

Humana Inc.

HUMNYSEHealthcare● Active
$352.93
+$2.85(+0.81%)
Market Cap$42.4B
P/E Ratio
52W High$353.5
52W Low$163.11
Overview

Humana Inc. (HUM) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

HUM · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $375.0M for FY2025 (fiscal year ending 2025-12-31), down 84.3% year-over-year The FCF margin was 0.3%. Five-year CAGR stands at -39.6%.

FY2025 Free Cash Flow$375.0M▼ -84.3% YoY
Trailing 12M (TTM)$1.27Btrailing 4 quarters sum
FCF Margin0.3%$375.0M ÷ revenue
3-Year CAGR-52.3%FY2022 → FY2025
5-Year CAGR-39.6%FY2020 → FY2025
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
hum free cash flow history · hum free cash flow chart · hum free cash flow growth rate · hum free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2025Latest$375.0M▼ 84.3%0.3%
FY2024$2.39B▼ 19.7%2.0%
FY2023$2.98B▼ 13.7%2.8%
FY2022$3.45B▲ +275.0%3.7%
FY2021$920.0M▼ 80.3%1.1%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
hum free cash flow 2025 · hum free cash flow 2024 · hum free cash flow 2023 · hum operating cash flow

FCF valuation metrics

Humana Inc. (HUM) trades at a FCF yield of 3.00% and a price-to-free-cash-flow ratio of 33.4x. FCF per share stands at $10.56, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
3.00%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$10.56
TTM FCF ÷ Shares Outstanding
Price / FCF
x33.4
Share Price ÷ FCF per Share
EV / FCF (TTM)
x40.4
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31
hum price to free cash flow · hum free cash flow yield · hum free cash flow per share · hum price to cash flow ratio

Cash flow statement summary

For FY2025, Humana Inc. generated $921.0M in operating cash flow and spent 546M in capital expenditures, yielding $375.0M in free cash flow.

Operating Activities
+$921.0M
Cash from core business operations
2025-12-31
Investing Activities
+$2.27B
CapEx, acquisitions & investments
2025-12-31
Financing Activities
−$1.22B
Buybacks, dividends & debt
2025-12-31
FCF FormulaOperating CF ($921.0M) − |CapEx| (546M) = FCF ($375.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
hum cash flow statement · hum cash flow statement 2025 · hum operating cash flow · hum cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
Humana Inc.
Humana Inc.YOU
HUM
$375.0M-84.3%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Humana Inc. (HUM) reported free cash flow of $375.0M for FY2025 (fiscal year ending 2025-12-31), down 84.3% year-over-year. The FCF margin was 0.3%.

Based on available data, Humana Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $4.67B in FY2020. The 5-year CAGR stands at -39.6%.

Humana Inc.'s FCF yield is 3.00% and price-to-FCF ratio is 33.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

HUM free cash flow · 8 questions

Humana Inc. free cash flow was $375.0M for FY2025, down 84.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.27B.

HUM free cash flowHUM FCFHUM FCF 2025HUM free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · Humana Inc. · Humana Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026